Many large and small pharmaceutical companies are turning to outsourcing the drug manufacture process to reduce capital investments on capacities and focus more on their core competencies. ...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
Intelligence Quotient for Innovation Research and Consultancy
IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.
We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Many large and small pharmaceutical companies are turning to outsourcing the drug manufacture process to reduce capital investments on capacities and focus more on their core competencies.
This report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery, preclinical development, clinical phases and commercial manufacturing of biologics.
The report covers all the drugs that are in various phases of development (Discovery, Preclinical and Clinical).
Pain is a debilitating condition, which arise due to various reasons which is not completely curable, but can be treated with pain management devices and surgery. Increase in the prevalence of chronic diseases and pain disorders, rise in aging population, and adverse effects of opioids, are driving the market.
Contrast agents/Media are substances that improve the visibility of specific organs, tissues or blood vessels and help in diagnostic imaging and interventional procedures using medical imaging tools. The increase in diagnostic imaging procedures and interventional imaging procedures are driving the market growth.
Diagnostic imaging is a non-invasive method for identifying and monitoring diseases or injuries by generating the images of internal anatomic structures and organs for diagnosing and to accurately determine various life threatening diseases such as cancer, cardiovascular, neurological disorders and others.
Sterilization is the process that eliminates all forms of microbial life and transmissible agents through drastic methods to prevent spread of disease, Increase in incidence of Hospital Acquired Infections (HAIs) is driving the market growth.
Nonalcholic steatohepatitis (NASH) also known as “fatty liver” causes inflammation and damages liver by accumulating fat in people who do not abuse alcohol, if untreated this leads to cirrhosis. This pipeline analysis gives comprehensive insights on various drugs being developed.
Structural heart (SH) devices are used for the treatment of congenital heart diseases and other diseases of heart that develop due to aging and reduce the effectiveness of functioning of the heart.
Nuclear medicine is a highly multi-disciplined specialty sector where sophisticated instruments and radiopharmaceuticals are used. Advancements in radioactive tracers are enabling study of metabolic activities in different area of body.
IQ4I
Latest News
Due to the increasing demand for biologics drugs and increased regulatory approvals for these drugs, there is huge demand for biologics manufacture and testing at various levels of clinical studies as well as commercial supply....
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
